It is reasonable to speculate that the FOXP3 promoter rs3761548 SNP, located in the upstream region, may indirectly interfere with the calcium–calcineurin signaling pathway, enhancing immune activation and inflammation, as well as the initiation and progression of T2DM and T2DN. Here, FOXP3 is linked to type 2 diabetes mellitus.